Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.06

€3.06

6.080%
0.18
6.080%
€33.73

€33.73

 
26.04.24 / Tradegate WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
23.04.24
-13.07%
buy
€33.73
23.04.24
-16.85%
buy
03.03.24
-59.04%
buy
26.01.24
-28.34%
€35.10
24.08.23
-15.98%
buy
€7.00
28.06.23
-26.34%
buy
Your prediction

Abeona Therapeutics Inc. Stock

Abeona Therapeutics Inc. dominated the market today, gaining €0.18 (6.080%).
Currently there is a rather positive sentiment for Abeona Therapeutics Inc. with 5 Buy predictions and 1 Sell predictions.
With a target price of 33 € there is potential for a 978.43% increase which would mean more than doubling the current price of 3.06 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.

Pros and Cons of Abeona Therapeutics Inc. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Abeona Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Abeona Therapeutics Inc. 6.080% -56.901% -56.534% 9.052% -35.032% -91.374% -
Ardelyx Inc. 3.600% -1.640% -12.849% 41.749% 3.737% -16.140% -
Salarius Pharmaceuticals Inc. 1.400% 3.333% 6.373% -63.833% -21.802% -98.281% -99.993%
Brainstorm Cell -5.760% -2.456% -18.607% -82.011% 114.009% -83.339% -

Comments

Prediction Buy
Perf. (%) -16.85%
Target price 33.728
Change
Ends at 23.04.25

Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $36.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Show more

Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ABEO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -15.98%
Target price 35.097
Change
Ends at 24.08.24

Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Show more